​

Merus (MRUS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

MRUS Stock Forecast

Merus (MRUS) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $97.67, with a high of $110.00 and a low of $90.00. This represents a 3.25% increase from the last price of $94.60.

$25 $42 $59 $76 $93 $110 High: $110 Avg: $97.67 Low: $90 Last Closed Price: $94.6

MRUS Stock Rating

Merus stock's rating consensus is Hold, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (45.45%), 12 Hold (54.55%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 22 0 12 10 Strong Sell Sell Hold Buy Strong Buy

MRUS Price Target Upside V Benchmarks

TypeNameUpside
StockMerus3.25%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts7912
Avg Price Target$97.00$97.89$96.58
Last Closing Price$94.60$94.60$94.60
Upside/Downside2.54%3.48%2.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-313--16
Sep, 25216---18
Aug, 25413---17
Jul, 25413---17
Jun, 25413---17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2025Leerink Partners$97.00$94.292.87%2.54%
Sep 30, 2025UBS$97.00$93.673.56%2.54%
Sep 30, 2025Barclays$97.00$93.673.56%2.54%
Sep 29, 2025H.C. Wainwright$97.00$93.663.57%2.54%
Sep 29, 2025Canaccord Genuity$97.00$93.663.57%2.54%
Sep 29, 2025Truist Financial$97.00$93.893.31%2.54%
Sep 29, 2025Eva ForteaWells Fargo$97.00$94.462.69%2.54%
Sep 16, 2025Barclays$112.00$66.9067.41%18.39%
Aug 25, 2025Industrial Alliance Securities$90.00$65.7436.90%-4.86%
May 23, 2025Etzer DaroutBMO Capital$110.00$55.1499.49%16.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 30, 2025UBSBuyNeutraldowngrade
Sep 30, 2025BMO CapitalOutperformMarket Performdowngrade
Sep 29, 2025H.C. WainwrightBuyNeutraldowngrade
Sep 29, 2025William BlairMarket Performdowngrade
Sep 29, 2025NeedhamBuyHolddowngrade
Sep 29, 2025CitigroupBuyNeutraldowngrade
Sep 16, 2025BarclaysOverweightinitialise
Aug 25, 2025Alliance Global PartnersBuyinitialise
May 23, 2025BMO CapitalOutperformOutperformhold
Dec 02, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.92$-1.73$-2.92$-3.00$-3.35----
Avg Forecast$-2.12$-1.85$-2.07$-2.48$-3.70$-3.75$-3.75$-2.51$-2.09
High Forecast$-0.78$-0.68$-1.02$-2.27$-3.49$-2.98$-2.27$5.03$-0.72
Low Forecast$-4.03$-3.51$-3.24$-2.80$-4.13$-4.64$-5.34$-6.95$-3.31
Surprise %37.74%-6.49%41.06%20.97%-9.46%----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$29.94M$49.11M$41.59M$43.95M$36.13M----
Avg Forecast$30.66M$46.25M$41.75M$46.99M$36.61M$53.12M$80.05M$252.82M$448.20M
High Forecast$51.90M$78.30M$59.81M$49.63M$52.10M$76.95M$81.59M$254.18M$649.26M
Low Forecast$15.75M$23.76M$25.38M$44.49M$29.77M$26.23M$78.51M$251.46M$221.31M
Surprise %-2.33%6.18%-0.39%-6.47%-1.30%----

Net Income Forecast

$-400M $-260M $-120M $20M $160M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-85.51M$-66.82M$-131.19M$-154.94M$-215.33M----
Avg Forecast$-109.52M$-68.51M$-75.33M$-154.94M$-196.45M$-196.54M$-196.28M$-159.21M$-108.00M
High Forecast$-40.30M$-54.80M$-60.27M$-123.95M$-180.01M$-153.77M$-117.11M$259.56M$-36.93M
Low Forecast$-208.19M$-82.21M$-90.40M$-185.93M$-212.88M$-239.30M$-275.45M$-358.75M$-170.99M
Surprise %-21.92%-2.47%74.15%-9.61%----

MRUS Forecast FAQ

Is Merus stock a buy?

Merus stock has a consensus rating of Hold, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 12 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Merus is a neutral investment for most analysts.

What is Merus's price target?

Merus's price target, set by 22 Wall Street analysts, averages $97.67 over the next 12 months. The price target range spans from $90 at the low end to $110 at the high end, suggesting a potential 3.25% change from the previous closing price of $94.6.

How does Merus stock forecast compare to its benchmarks?

Merus's stock forecast shows a 3.25% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Merus over the past three months?

  • October 2025: 0% Strong Buy, 18.75% Buy, 81.25% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 11.11% Strong Buy, 88.89% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 23.53% Strong Buy, 76.47% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Merus’s EPS forecast?

Merus's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.75, marking a 11.94% increase from the reported $-3.35 in 2024. Estimates for the following years are $-3.75 in 2026, $-2.51 in 2027, and $-2.09 in 2028.

What is Merus’s revenue forecast?

Merus's average annual revenue forecast for its fiscal year ending in December 2025 is $53.12M, reflecting a 47.01% increase from the reported $36.13M in 2024. The forecast for 2026 is $80.05M, followed by $252.82M for 2027, and $448.2M for 2028.

What is Merus’s net income forecast?

Merus's net income forecast for the fiscal year ending in December 2025 stands at $-197M, representing a -8.73% decrease from the reported $-215M in 2024. Projections indicate $-196M in 2026, $-159M in 2027, and $-108M in 2028.